Form CORRESP - Correspondence:
SEC Accession No. 0001628280-25-040570
Filing Date
2025-08-15
Accepted
2025-08-15 17:07:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 84294
2 image_0a.jpg GRAPHIC 278098
  Complete submission text file 0001628280-25-040570.txt   468358
Mailing Address 1600 WEST END AVENUE SUITE 1300 NASHVILLE TN 37203
Business Address 1600 WEST END AVENUE SUITE 1300 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)